Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia

Area of Science:

• Pulmonary Medicine
• Mathematical Biology
• Infectious Diseases

Background:

• Early COVID-19 presents with silent hypoxia and poor oxygenation despite minimal lung damage.
• Impaired hypoxic pulmonary vasoconstriction was a suspected cause, but thrombotic microembolism is gaining attention.
• Physiological plausibility of severe perfusion redistribution in COVID-19 remains unquantified.

Purpose of the Study:

• To determine if severe perfusion redistribution can explain hypoxemia in early COVID-19.
• To investigate the role of pulmonary embolism and ventilation-perfusion mismatch.
• To model the physiological mechanisms underlying COVID-19-related hypoxemia.

Main Methods:

• Development of a mathematical model simulating lung physiology.
• Incorporation of parameters for pulmonary embolism, ventilation-perfusion mismatch, and shunt.
• Analysis of perfusion and ventilation dynamics in injured and non-injured lung regions.

Main Results:

• The model demonstrates that pulmonary venous admixture in early COVID-19 is explained by pulmonary embolism and V/Q mismatch in healthy lung areas.
• Normal perfusion of injured lung regions contributes to the observed hypoxemia.
• Model simulations indicate that severe hypoxemia requires extensive perfusion defects or significant V/Q mismatch.

Conclusions:

• Pulmonary embolism and ventilation-perfusion mismatch are key contributors to early COVID-19 hypoxemia.
• The severity of hypoxemia in COVID-19 is not solely explained by lung injury but by complex perfusion abnormalities.
• Mathematical modeling provides a framework for understanding the pathophysiology of COVID-19-induced respiratory compromise.